- Home
- ->
- Industry News
Sep 29, 2022: “With this guidance, FDA intends to continue building upon the Agency’s existing priorities and initiatives recently announced within the FDA Overdose Prevention Framework to address the evolving opioid public health emergency, specifically by encouraging harm reduction by seeking to expand availability and access to naloxone”
Outside link:
FDA is issuing guidance to help address some of the obstacles to naloxone access identified during community engagements